Diltiazem Hydrochloride Injection, Solution
Product Images NDC 25021-319

4 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 25021-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dil0b 0001 01)

Structural Formula (Dil0b 0001 01)
Chemical structure of diltiazem hydrochloride showing the molecular arrangement including aromatic rings and functional groups, with the hydrochloride indicated as a separate component.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 02)

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 02)
Label for Diltiazem HCl Injection, 25 mg per 5 mL (equivalent to 5 mg per mL) single-dose vial by Sagent Pharmaceuticals. The label indicates the product is for direct intravenous bolus injection and continuous intravenous infusion, includes NDC 25021-319-05, barcode, manufacturing details, lot and expiration placeholders, and storage instructions to discard unused portions.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 03)

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 03)
Label for Diltiazem Hydrochloride Injection 50 mg per 10 mL (5 mg per mL) intravenous solution by Sagent Pharmaceuticals. The label includes dosage instructions, barcode, lot and expiration fields, and manufacturing details indicating it is made in India for Sagent Pharmaceuticals, USA.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 04)

Package Label – Principal Display Panel – Vial Label (Dil0b 0001 04)
Label for Diltiazem Hydrochloride Injection 125 mg per 25 mL (5 mg per mL) single-dose vial by Sagent Pharmaceuticals. The label indicates the drug is a sterile, nonpyrogenic solution for intravenous use, preservative-free with natural rubber stopper. It includes storage instructions and manufacturer information, mentioning the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.